Patients With Brain Metastases From HER2-positive Breast Cancer

Mise à jour : Il y a 5 ans
Référence : NCT02135159

Femme et Homme

  • | Pays :
  • France
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this study is to determine the optimal sequences of combined trastuzumab emtansine (T-DM1) and whole-brain radiotherapy in patients presenting brain metastases from HER2-positive breast cancer in terms of acute toxicities and blood/cerebrospinal fluid T-DM1 pharmacokinetics.


Critère d'inclusion

  • HER2-positive breast cancer

Liens